齊默巴奧米特控股 ZBH 深 滬
等待開盤 09-06 09:30:00 美东时间
105.73
+0.970
+0.93%
華盛通- 最 高106.20
- 今 開104.77
- 成交量 116.84万股
- 最 低 104.49
- 昨 收 104.76
- 總市值 209.35亿
- 52周最高 114.20
- 市盈率 靜 23.85
- 換手率 0.59%
- 52周最低 88.98
- 委 比 -92.00%
- 總股本 1.98亿
- 歷史最高 172.48
- 量 比 1.19
- 振 幅 1.63%
- 歷史最低 32.18
- 每 手 1
- 風險率 7.93%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Zimmer Biomet Issues CHF 600 Million Debt Securities
Zimmer Biomet Holdings ( ($ZBH) ) has shared an announcement. On September 4, 2...
09-05 04:53
Zimmer Biomet declares $0.24 dividend
Zimmer Biomet (NYSE:ZBH) declares $0.24/share quarterly dividend, in line with previous. Forward yield 0.89% Payable Oct. 31; for shareholders of record Sept. 30; ex-div Sept. 30. See ZBH Dividend Sco...
08-27 19:08
Zimmer Biomet to Present at the Annual Morgan Stanley Healthcare Conference
WARSAW, Ind., Aug. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the Annua...
08-25 19:30
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
A Glimpse Into The Expert Outlook On Zimmer Biomet Holdings Through 5 Analysts
Zimmer Biomet Holdings (NYSE:ZBH) underwent analysis by 5 analysts in the last ...
08-09 05:02
Zimmer Biomet Holdings Raises FY2025 Adj EPS Guidance from $7.90-$8.10 to $8.10-$8.30 vs $7.97 Est; Narrows FY2025 Sales Guidance from $8.117B-$8.309B to $8.190B-$8.270B vs $8.184B Est
Financial GuidanceThe Company is updating its full-year 2025 financial guidance to tighten full-year 2025 reported, constant currency and organic constant currency1 revenue guidance and increase adjusted2 earnings per
08-07 18:33
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Treace Announces Peer-Reviewed Publication of Four-Year Results of the ALIGN3D™ Lapiplasty® Multicenter Prospective Clinical Study
Treace Medical Concepts announced the publication of four-year interim results from its ALIGN3D™ study, showcasing positive outcomes of the Lapiplasty® Procedure for hallux valgus. Results include early return to weight-bearing (7.7 days), low recurrence rates (0.8% HVA>20°), and significant pain reduction (81%) and functional improvement (89%) in patients.
08-05 20:05
What Does the Market Think About Zimmer Biomet Holdings?
Zimmer Biomet Holdings's (NYSE:ZBH) short percent of float has fallen 13.09% si...
07-28 21:00
